POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 AND HIV-2 REPLICATION BY A CLASS OF BICYCLAMS INTERACTING WITH A VIRAL UNCOATING EVENT
被引:242
作者:
DECLERCO, E
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
DECLERCO, E
YAMAMOTO, N
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
YAMAMOTO, N
PAUWELS, R
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
PAUWELS, R
BABA, M
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
BABA, M
SCHOLS, D
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
SCHOLS, D
NAKASHIMA, H
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
NAKASHIMA, H
BALZARINI, J
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
BALZARINI, J
DEBYSER, Z
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
DEBYSER, Z
MURRER, BA
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
MURRER, BA
SCHWARTZ, D
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
SCHWARTZ, D
THORNTON, D
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
THORNTON, D
BRIDGER, G
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
BRIDGER, G
FRICKER, S
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
FRICKER, S
HENSON, G
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
HENSON, G
ABRAMS, M
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
ABRAMS, M
PICKER, D
论文数: 0引用数: 0
h-index: 0
机构:JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
PICKER, D
机构:
[1] JOHNSON MATTHEY TECHNOL CTR, READING RG4 9NH, ENGLAND
[2] JOHNSON MATTHEY PHARMACEUT RES, W CHESTER, PA 19380 USA
A series of bicyclams have been shown to be potent and selective inhibitors of human immunodeficiency virus (HIV). The compounds are inhibitory to the replication of various HIV-1 and HIV-2 strains in various human T-cell systems, including peripheral blood lymphocytes, at 0.14-1.4-mu-M, without being toxic to the host cells at 2.2 mM. The bicyclam JM2763 is active against 3'-azido-3'-deoxythymidine (zidovudine; AZT)-resistant HIV-1 strains and acts additively with AZT. Mechanism of action studies revealed that the bicyclams (i.e., JM2763) interact with an early event of the retrovirus replicative cycle, which could be tentatively identified as a viral uncoating event.